Next week CEO speaks loud9 Nov 2017 10:53
Oxford BioMedica to Present at the Jefferies 2017 London Healthcare Conference
Oxford, UK - 9 November 2017: Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, today announces that John Dawson, Chief Executive Officer, will be speaking at the Jefferies 2017 London Healthcare Conference at 13:20 GMT on 15 November 2017.